/Investor DB

SV Health Investors — 2020 Investments

3 investments dated 2020 · listed companies and verified rows first · show all

Stimwave Technologiesstimwave.comAug 2020SEC filingmedium confidence

BiotechHealthtechPompano Beach, US

Laura Tyler Perryman(Director)Regina Groves(Executive Officer, Director)Virginia Sullivan(Executive Officer)Marc Loev(Director)Richard Chen Mao(Director)Gary Perryman(Director)

Board seatPaul LaViolette· per SEC Form D · $8M raise · filed Sep 2020

Co-investorsEmergent Medical Partners, LLP

Kinaset Therapeuticskinasettherapeutics.comin𝕏Series A · Nov 2020 · $40M

Kinaset Therapeutics is a drug developer working on KN-002, a therapeutic candidate for treating severe asthma across patients regardless of the underlying cause of inflammation.

BiotechHealthtechMedfield, US

Roger Heerman(Chief Business/Operating Officer / Co-Founder)inFrazer Morgan(Chief Development Officer / Co-Founder)inRobert Clarke(Chief Executive Officer / Board Member / Co-Founder)Christopher O’Brien(Chief Medical Officer)

BoardJamil Beg(Director of the Issuer)inTom King(Director of the Issuer)

Co-investors5AM VenturesAtlas VentureRA CapitalEQT Life SciencesGimvSixty Degree Capital+3 more

Leitersleiters.cominSeed · Dec 2020

Leiters Health is an FDA-registered 503B outsourcing facility that produces sterile compounded preparations for hospitals, surgery centers, and ophthalmic use.

BiotechHealthtechMedical DevicesDenver, US

Co-investorsCorewell Health VenturesDementia Discovery FundEscalate Capital PartnersFrazier Healthcare PartnersH.I.G. CapitalH.I.G. HealthBridge Partners+4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.